Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. The company continues to prioritize resources to maximize opportunities for ongoing and upcoming product launches, reflecting its commitment to operational flexibility and adaptability in response to market demands. In 2017, Merck experienced a network cyber-attack that disrupted worldwide operations, including manufacturing and sales. Despite this, the company managed to fulfill orders and ship products, demonstrating resilience under challenging conditions. The cyber-attack resulted in an unfavorable effect on sales, but Merck's operational continuity was maintained through effective crisis management and resource allocation strategies. Additionally, the company faced external pressures from generic competition and pricing actions that negatively affected revenue performance. Merck's strategic initiatives include augmenting its portfolio with external innovation, as evidenced by collaborations with AstraZeneca and acquisitions aimed at enhancing its capabilities in cancer immunotherapy. The company emphasizes the importance of inter-organizational collaboration and knowledge absorption to drive service innovation and maintain a competitive advantage in a turbulent market. Merck's focus on research and development reflects its commitment to addressing unmet medical needs and adapting to environmental perturbations. The company continues to evaluate its pipeline, ensuring that its strategic response to market changes aligns with its major objectives. The termination of the joint venture with Sanofi Pasteur led to a reconfiguration of vaccine sales in Europe, illustrating the company's ability to reconstitute its operations in response to significant changes in its business environment. Merck's financial profile supports its strategic planning and resource management, enabling it to navigate complex situations effectively. The company's commitment to learning organization principles fosters a culture of resilience, allowing it to confront challenges and leverage opportunities for growth. Merck's operational management strategies, including the prioritization of resources and investment in research, are designed to enhance organizational effectiveness and performance under pressure. The company recognizes the importance of emotional resources and social capital in fostering a resilient organizational culture. Overall, Merck's multifaceted approach to organizational resilience encompasses risk assessment, crisis agency, and proactive measures to ensure sustainability and long-term success in a dynamic and competitive landscape.